Related Experiment Video
Updated: Feb 16, 2026

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis
Mitchell Lawrence Jones1, Jorge G Ganopolsky, Alain Labbé
1Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Physiology, Artificial Cells and Organs Research Centre, Faculty of Medicine McGill University, 3775 University Street, Montreal, QC, Canada. mitchell.jones@mcgill.ca
Abstract:
Microbial and fungal infections are a significant consideration in the etiology of all wounds. Numerous antimicrobial and antifungal formulations have been developed with varying degrees of efficacy and stability. Here, we report a nitric oxide producing probiotic adhesive patch device and investigate its antimicrobial and antifungal efficacy in vitro. This probiotic patch utilizes the metabolic activity of immobilized lactic acid bacteria, glucose, and nitrite salts for the production of gaseous nitric oxide (gNO), which is used as an antimicrobial agent against bacterial and fungal pathogens. Results show that application of gNO-producing probiotic patches to cultures of E. coli, S. aureus, P. aeruginosa, MRSA, T. mentagrophytes, and T. rubrum resulted in complete cell death at between 4 and 8 h, and application to cultures of A. baumannii, resulted in fewer than ten colonies detected per milliliter at 6 h. These results demonstrate that a gNO-producing probiotic patch device containing bacteria, glucose, and nitrite salts can produce sufficient levels of gNO over a therapeutically relevant duration to kill common bacterial and fungal wound pathogens in humans.
Insights
A novel probiotic patch effectively kills wound pathogens by producing nitric oxide (NO). This innovative antimicrobial wound care solution demonstrates significant efficacy against common bacterial and fungal infections in vitro.
Area of Science:
- Biotechnology
- Microbiology
- Wound Healing
Background:
- Microbial and fungal infections are a major cause of wound complications.
- Existing antimicrobial and antifungal treatments have variable efficacy and stability.
- Novel strategies are needed for effective wound infection management.
Purpose of the Study:
- To develop and evaluate a nitric oxide (NO)-producing probiotic adhesive patch for antimicrobial and antifungal applications.
- To investigate the in vitro efficacy of the probiotic patch against common wound pathogens.
Main Methods:
- Immobilized lactic acid bacteria, glucose, and nitrite salts were used to generate gaseous nitric oxide (gNO).
- The gNO-producing probiotic patch was applied to cultures of various bacterial and fungal pathogens.
- Antimicrobial and antifungal efficacy was assessed by monitoring pathogen survival over time.
Main Results:
- The gNO-producing probiotic patch achieved complete cell death for E. coli, S. aureus, P. aeruginosa, MRSA, T. mentagrophytes, and T. rubrum within 4-8 hours.
- Significant reduction in A. baumannii colonies (<10 CFU/mL) was observed at 6 hours.
- The patch demonstrated sustained gNO production over a therapeutically relevant duration.
Conclusions:
- A gNO-producing probiotic patch effectively eliminates common bacterial and fungal wound pathogens in vitro.
- This device offers a promising new approach for antimicrobial wound care.
- The patch utilizes a probiotic mechanism for sustained gNO release and pathogen eradication.
Related Concept Videos
Self-Efficacy
Antimicrobial Effectiveness
Nitric Oxide Signaling Pathway
Oxidation Numbers
Long-patch Base Excision Repair
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

